Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients
- 1 July 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56, S134-S136
- https://doi.org/10.1046/j.1523-1755.1999.07133.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysisAtherosclerosis, 1997
- Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media ThicknessCirculation, 1997
- Effects of the Nicotinic Acid Analogue Niceritrol on Lipoprotein Lp(a) and Coagulation-Fibrinolysis Status in Patients with Chronic Renal Failure on HemodialysisNephron, 1997
- High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremiaKidney International, 1995
- Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatmentKidney International, 1995
- Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: Effect of a fibric acid, clinofibrateKidney International, 1993
- Impaired metabolism of high density lipoprotein in uremic patientsKidney International, 1992